NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating the Board of Directors of Albany Molecular Research, Inc. (NASDAQGS: AMRI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to GTCR LLC and The Carlyle Group. Under the terms of the deal, Albany Molecular shareholders will receive $21.75 per share.
The investigation concerns whether the Albany Molecular Board of Directors breached their fiduciary duties to Albany Molecular stockholders by failing to adequately shop the Company before entering into this transaction and whether GTCR and The Carlyle Group are underpaying for Albany Molecular shares, thus unlawfully harming Albany Molecular stockholders.
If you own common stock in Albany Molecular and wish to obtain additional information, please contact Vincent Wong, Esq. either via email email@example.com, by telephone at 212.425.1140, or http://docs.wongesq.com/AMRI-Info-Request-Form-1621.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.